VIANEX Group Receives Prestigious Award for Social Contribution at Prix Galien Greece 2025

In a special ceremony, the VIANEX Group received the honorary award ‘Pharma For Society’ as part of the Prix Galien Greece 2025 — the most prestigious event in the field of pharmaceutical innovation. This award recognizes initiatives with significant positive societal impact. The recognition confirms VIANEX’s longstanding social legacy in Greece and its dedication to promoting public health centered around people. The ceremony took place on Thursday, April 24, 2025, at the Athens Concert Hall, where the group was represented by Vice President Mr. Konstantinos Panagoulis. In response to the award, the President and Managing Director of VIANEX, Mr. Dimitris Giannakopoulos, stated: “This honorary distinction is a profound moral reward for VIANEX after a century of continuous contribution to health. It reminds us that the true value of success is measured by its impact on society. We will continue with the same commitment to support society, innovate, and serve humanity. This is our vision and mission for the next 100 years.” Vice President of VIANEX, Mr. Konstantinos Panagoulis, remarked upon receiving the award: “The ‘Pharma For Society’ award is a great honor and acknowledgment of our 100-year contribution to the pharmaceutical field. At VIANEX, we remain steadfastly committed to people, guided by the benefit of patients and a sense of responsibility towards society. This recognition further strengthens our commitment to leaving a positive mark on health, the economy, and Greek society.” The VIANEX Group continues its journey consistently, with unwavering values of innovation, social responsibility, and a steadfast commitment to a better future for all.